We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tes... read more Featured Products: More products

Download Mobile App

DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: LIAISON XS delivers a high technology solution for immunochemistry tests (Photo courtesy of DiaSorin)
Image: LIAISON XS delivers a high technology solution for immunochemistry tests (Photo courtesy of DiaSorin)

DiaSorin S.p.A. (‎Saluggia‎, Italy) is exhibiting its range of advanced diagnostic solutions at this year's WorldLab-EuroMedLab that are designed to help clinicians in the management of emergency patients.

At EuroMedLab Rome 2023, DiaSorin is presenting its industry-leading offering of fully-automated chemiluminescent immunoassay (CLIA) panels, designed specifically for diagnosing infectious diseases. The highlight of the event, however, is the LIAISON MeMed BV test - DiaSorin's groundbreaking solution for rapidly and accurately distinguishing between bacterial and viral infections. The LIAISON MeMed BV test is the first of its kind, a fully automated solution that uses data based on the host's response. This innovative test aids physicians in accurately distinguishing between bacterial and viral infections, thereby facilitating quicker, more informed decisions regarding treatment and patient management. Moreover, compared to conventional growth-based microbiology methods, this test enhances lab operational efficiency by saving time and reducing labor through its fully automated and high-throughput approach.

In addition, DiaSorin is highlighting the capabilities of its LIAISON XS analyzer - a high-tech solution for immunochemistry tests. The analyzer enables laboratories to boost both efficiency and clinical effectiveness for routine and specialty testing. Also on display at the event is the LIAISON XL, a fully automated chemiluminescence analyzer, designed to carry out complete sample processing (including sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.), measurement, and evaluation. The LIAISON XL, with its innovative features such as a fully automated solution, superior result quality, flexible configuration, and high efficiency, has the potential to significantly improve the productivity of immunoassay labs.

Related Links:
DiaSorin S.p.A.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article


Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more


view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.